Pharmaceutical Technology

SEPTEMBER 14, 2022

API peptides and proteins-based drugs have gained much attention in the past decade. Victoza, Copaxone, Lupron, Zoladex, Sandostatin, and Somatuline are some of the popularly marketed peptide API therapeutic drugs while more than 600 peptide-based pharmacological leads are being investigated worldwide, across various phases of development.

Protein 130

Protein Marketing Manufacturing Reagent 130

Drug Discovery World

DECEMBER 23, 2022

“We are pleased to partner with these prestigious biotechnology companies in advancing cell therapies for the betterment of those that are sick and in need,” said Michael, Head of GMP Business Development at GenScript.

Gene Therapy 52

Gene Therapy Gene Reagent Clinical Trials 52

pharmaphorum

DECEMBER 16, 2022

Dopavision, a DTx company in the eye health space, has brought on ophthalmology and neuroscience expert Dirk Sauer , a veteran of Novartis Pharma, to advise the company as it continues to develop MyopiaX, a digital therapeutic for childhood myopia control. AI and robotics hires. McKinnell, Jr. to support the company’s growth.

Behavioural Health 52

Behavioural Health Reagent Gene Therapy Production 52

Drug Discovery World

JANUARY 30, 2024

Natalia Elizalde, Chief Business Development Officer, VIVEbiotech, says that Dr Naldini’s award represents the significant benefits and demonstrated safety of the therapies developed using lentiviral vectors that are being used for more and more clinical trials and more prevalent diseases.

Gene Therapy 71

Gene Therapy Manufacturing Gene Clinical Trials 71

Drug Discovery World

NOVEMBER 30, 2023

Lightcast is developing a novel, programmable microfluidic platform that allows precise and highly flexible control of individual microdroplets using software-generated light patterns. GSK has developed high-throughput mammalian and E.

Antibody 59

Antibody Protein Engineer In-Vivo 59

The Pharma Data

OCTOBER 14, 2020

They can be cultured to test drugs. We are looking forward to exploring business development opportunities with innovative companies in these two fields of use who are interested in a technology platform offering a real competitive advantage” said Savran. “We expect our platform to be useful in a wide variety of conditions.

Clinical Trials 40

Clinical Trials Clinical Trials Trials Genome 40

Drug Discovery World

MAY 16, 2023

Lentiviral vectors demand Naiara Tejados, Head of Marketing and Technology Development at VIVEbiotech & Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, anticipate that 2023 will be a very good year for VIVEbiotech, due to the increasing demand for lentiviral vectors.

Gene Therapy 52

Gene Therapy Gene Manufacturing Marketing 52